Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication. It is not available as a treatment. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients, and it does not offer access to any therapy.
← FixCancer.org

Medical and Research Disclaimer

Last updated July 12, 2026

This page is for general educational and informational purposes only. It is not medical advice and is not a substitute for professional diagnosis or treatment. Consult a licensed healthcare provider before making any medical decision.

Read this disclaimer before relying on anything published here.

General educational information only

The content on this site is provided for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment, and it does not create a physician and patient relationship. Do not delay or disregard professional medical care based on anything you read here.

Consult a licensed healthcare provider

Always seek the advice of a licensed physician or other qualified healthcare provider with any questions about a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this site.

No FDA evaluation or approval

The statements on this site, and any products or therapies referenced, have not been evaluated or approved by the United States Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure, or prevent any disease.

No product or therapy is offered

No product or therapy is offered, sold, promoted, or provided through this site. This site does not sell, ship, dispense, prescribe, or arrange any product, treatment, or clinical service.

No guarantee of results

Individual results are not implied or guaranteed. Outcomes vary. References to research, including early stage, preclinical, or laboratory work, do not establish safety or effectiveness in humans.

Research references

Citations and links are provided for education only. They are not endorsements and may include preprints or other works that have not completed peer review.

Further reading

See the FDA public safety information on unapproved regenerative and stem cell products and 21 CFR Part 1271 for the regulatory framework. Links are available through the FDA website at fda.gov.